EDGAR Filing Documents for 0001193125-22-101653

Form 8-K - Current report:

SEC Accession No. 0001193125-22-101653

Filing Date

2022-04-11

Accepted

2022-04-11 16:08:16

Documents

Period of Report

2022-04-08

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d329060d8k.htm iXBRL	8-K	40925
2	EX-3.1	d329060dex31.htm	EX-3.1	5815
3	EX-99.1	d329060dex991.htm	EX-99.1	10579
	Complete submission text file	0001193125-22-101653.txt		189515

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	zsan-20220408.xsd	EX-101.SCH	2873
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	zsan-20220408_lab.xml	EX-101.LAB	17982
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	zsan-20220408_pre.xml	EX-101.PRE	11270
8	EXTRACTED XBRL INSTANCE DOCUMENT	d329060d8k_htm.xml	XML	3471

Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555

Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200

Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)